| 臺大學術典藏 |
2021-07-20T03:15:18Z |
Association between regional economic status and renal recovery of dialysis-requiring acute kidney injury among critically ill patients
|
Shiao C.-C.; Chang Y.-H.; Yang Y.-F.; Lin E.-T.; Pan H.-C.; Chang C.-H.; Huang C.-T.; Kao M.-T.; Chuang T.-F.; Chen Y.-C.; Kan W.-C.; Kuo F.-C.; Chen T.-C.; Chen Y.-M.; Wu C.-J.; Liou H.-H.; Lu K.-C.; Wu V.-C.; TZONG-SHINN CHU; Wu M.-S.; Wu K.-D.; Fang J.-T.; Huang C.-C. |
| 臺大學術典藏 |
2021-06-25T07:22:04Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
YU-FENG LIN; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2021-06-25T07:22:03Z |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: A randomized, open-label, parallel-group study
|
YU-FENG LIN; Chien C.-T.; Kan W.-C.; Chen Y.-M.; Chu T.-S.; Hung K.-Y.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T09:06:37Z |
Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: A Retrospective Multicenter Cohort Study
|
Chen C.-H.; Wu H.-Y.; Wang C.-L.; Yang F.-J.; Wu P.-C.; Hung S.-C.; Kan W.-C.; Yang C.-W.; CHIH-KANG CHIANG; Huang J.-W.; Hung K.-Y. |
| 臺大學術典藏 |
2021-05-06T02:57:46Z |
Urinary biomarkers predict advanced acute kidney injury after cardiovascular surgery
|
Wang J.-J.; NAI-HSIN CHI; Huang T.-M.; Connolly R.; Chen L.W.; Chueh S.-C.J.; Kan W.-C.; Lai C.-C.; Wu V.-C.; Fang J.-T.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-27T06:53:36Z |
SiO2 supported niobium oxides with active acid sites for the catalytic acetalization of glycerol
|
Kao, L.C.;Kan, W.C.;Martin-Aranda, R.M.;Guerrero-Perez, M.O.;Bañares, M.Á.;Liou, S.Y.H.; Kao, L.C.; Kan, W.C.; Martin-Aranda, R.M.; Guerrero-Perez, M.O.; Bañares, M.Á.; Liou, S.Y.H.; YA-HSUAN LIOU |
| 臺大學術典藏 |
2021-01-27T03:23:37Z |
SiO2 supported niobium oxides with active acid sites for the catalytic acetalization of glycerol
|
Kao, L.C.;Kan, W.C.;Martin-Aranda, R.M.;Guerrero-Perez, M.O.;Bañares, M.Á.;Liou, S.Y.H.; Kao, L.C.; Kan, W.C.; Martin-Aranda, R.M.; Guerrero-Perez, M.O.; Bañares, M.Á.; Liou, S.Y.H.; YA-HSUAN LIOU |
| 臺大學術典藏 |
2021-01-12T03:32:23Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; SHUEI-LIONG LIN; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T08:38:30Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Wen-Chih Chiang;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Wu M.-S.; Wu K.-D.; Tsai T.-J.; Yen C.-J.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; WEN-CHIH CHIANG |
| 臺大學術典藏 |
2020-12-24T08:11:52Z |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: A randomized, open-label, parallel-group study
|
Lin Y.-F.;Chien C.-T.;Kan W.-C.;Chen Y.-M.;Chu T.-S.;Hung K.-Y.;Tsai T.-J.;Wu K.-D.;Ming-Shiou Wu; Lin Y.-F.; Chien C.-T.; Kan W.-C.; Chen Y.-M.; Chu T.-S.; Hung K.-Y.; Tsai T.-J.; Wu K.-D.; MING-SHIOU WU |
| 臺大學術典藏 |
2020-12-24T08:11:52Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
MING-SHIOU WU; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Ming-Shiou Wu |
| 臺大學術典藏 |
2020-12-24T07:43:47Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu K.-D.; Wu M.-S.; TUN-JUN TSAI; Yen C.-J.; Chiang W.-C.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F. |
| 臺大學術典藏 |
2020-12-24T07:43:45Z |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: A randomized, open-label, parallel-group study
|
Lin Y.-F.; Chien C.-T.; Kan W.-C.; Chen Y.-M.; Chu T.-S.; Hung K.-Y.; TUN-JUN TSAI; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:36Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu M.-S.; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; JENQ-WEN HUANG; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Jenq-Wen Huang;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:21Z |
Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: A Retrospective Multicenter Cohort Study
|
Chen C.-H.;Wu H.-Y.;Wang C.-L.;Yang F.-J.;Wu P.-C.;Hung S.-C.;Kan W.-C.;Yang C.-W.;Chiang C.-K.;Jenq-Wen Huang;Hung K.-Y.; Chen C.-H.; Wu H.-Y.; Wang C.-L.; Yang F.-J.; Wu P.-C.; Hung S.-C.; Kan W.-C.; Yang C.-W.; Chiang C.-K.; JENQ-WEN HUANG; Hung K.-Y. |
| 臺大學術典藏 |
2020-12-24T06:30:39Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Chiang W.-C.; Huang J.-W.; Kao T.-W.; Huang C.-Y.; Lin S.-L.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; YUNG-MING CHEN; Lin Y.-F.;Yung-Ming Chen;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Lin Y.-F.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T06:30:36Z |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: A randomized, open-label, parallel-group study
|
Lin Y.-F.; Chien C.-T.; Kan W.-C.; YUNG-MING CHEN; Chu T.-S.; Hung K.-Y.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T06:30:17Z |
Association between regional economic status and renal recovery of dialysis-requiring acute kidney injury among critically ill patients
|
Huang C.-C.; Fang J.-T.; Wu K.-D.; Wu M.-S.; Chu T.-S.; Wu V.-C.; Lu K.-C.; Liou H.-H.; Wu C.-J.; YUNG-MING CHEN; Chen T.-C.; Kuo F.-C.; Kan W.-C.; Chen Y.-C.; Chuang T.-F.; Shiao C.-C.; Chang Y.-H.; Yang Y.-F.; Lin E.-T.; Pan H.-C.; Chang C.-H.; Huang C.-T.; Kao M.-T. |
| 臺大學術典藏 |
2020-12-23T02:57:18Z |
Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods
|
Weng C.-J.; Tsai J.-P.; You Z.-H.; Chen C.-M.; Kuo F.-C.; Lin H.Y.-H.; Kan W.-C.; Wang J.-J.; Chien K.-L.; Lu K.-C.; Liou H.-H.; Hu F.-C.; Chen T.-C.; Lin C.-Y.; Lee K.-H.; Huang C.-T.; Sun C.-Y.; Kao C.-C.; Shiao C.-C.; Wu P.-C.; VIN-CENT WU; Lin J.-H.; Pan H.-C.; Yang Y.-F.; Lai T.-S.; Huang T.-M.; Wu C.-H.; Yang W.-S.; Wu C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; Wu K.-D.; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs) |
| 臺大學術典藏 |
2020-12-23T02:57:07Z |
Urinary biomarkers predict advanced acute kidney injury after cardiovascular surgery
|
Wu K.-D.; Chu T.-S.; Fang J.-T.; VIN-CENT WU; Lai C.-C.; Wang J.-J.;Chi N.-H.;Huang T.-M.;Connolly R.;Chen L.W.;Chueh S.-C.J.;Kan W.-C.;Lai C.-C.;Vin-Cent Wu;Fang J.-T.;Chu T.-S.;Wu K.-D.; Wang J.-J.; Chi N.-H.; Huang T.-M.; Connolly R.; Chen L.W.; Chueh S.-C.J.; Kan W.-C. |
| 臺大學術典藏 |
2020-12-23T02:56:44Z |
Association between regional economic status and renal recovery of dialysis-requiring acute kidney injury among critically ill patients
|
VIN-CENT WU; Lu K.-C.; Liou H.-H.; Wu C.-J.; Chen T.-C.; Chen Y.-M.; Kuo F.-C.; Kan W.-C.; Chen Y.-C.; Chuang T.-F.; Kao M.-T.; Huang C.-T.; Shiao C.-C.;Chang Y.-H.;Yang Y.-F.;Lin E.-T.;Pan H.-C.;Chang C.-H.;Huang C.-T.;Kao M.-T.;Chuang T.-F.;Chen Y.-C.;Kan W.-C.;Kuo F.-C.;Chen T.-C.;Chen Y.-M.;Wu C.-J.;Liou H.-H.;Lu K.-C.;Vin-Cent Wu;Chu T.-S.;Wu M.-S.;Wu K.-D.;Fang J.-T.;Huang C.-C.; Shiao C.-C.; Chang Y.-H.; Yang Y.-F.; Lin E.-T.; Pan H.-C.; Chang C.-H.; Chu T.-S.; Wu M.-S.; Wu K.-D.; Fang J.-T.; Huang C.-C. |
| 臺大學術典藏 |
2020-11-27T03:25:25Z |
Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: A Retrospective Multicenter Cohort Study
|
Chen C.-H.; Wu H.-Y.; Wang C.-L.; Yang F.-J.; Wu P.-C.; Hung S.-C.; Kan W.-C.; Yang C.-W.; Chiang C.-K.; Huang J.-W.; KUAN-YU HUNG |
| 臺大學術典藏 |
2020-11-27T03:25:01Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.;Chen Y.-M.;Kuan-Yu Hung;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Lin Y.-F.; Chen Y.-M.; KUAN-YU HUNG; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:24:49Z |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: A randomized, open-label, parallel-group study
|
Lin Y.-F.;Chien C.-T.;Kan W.-C.;Chen Y.-M.;Chu T.-S.;Kuan-Yu Hung;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Lin Y.-F.; Chien C.-T.; Kan W.-C.; Chen Y.-M.; Chu T.-S.; KUAN-YU HUNG; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 臺大學術典藏 |
2020-10-14T06:31:01Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu M.-S.; Wu K.-D.; Tsai T.-J.; CHUNG-JEN YEN; Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C. |
